|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Operating activities: | ||||
| Net income (loss) | ||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | ||||
| Equity-based compensation | ||||
| Performance allocation compensation | ||||
| Net losses (gains) from investment activities | ||||
| Consolidated Entity, Excluding VIE | ||||
| Total net losses (gains) from investment activities | ||||
| Capital allocation-based income | ||||
| Depreciation and amortization | ||||
| Non-cash lease expense | ||||
| Other non-cash activities | ||||
| Unrealized gains from investment activities of consolidated Public SPACs | ||||
| Changes in operating assets and liabilities: | ||||
| Purchases of investments | ||||
| Consolidated Entity, Excluding VIE | ||||
| Variable Interest Entity, Not Primary Beneficiary | ||||
| Proceeds from investments | ||||
| Consolidated Entity, Excluding VIE | ||||
| Variable Interest Entity, Not Primary Beneficiary | ||||
| Purchases of investments | ||||
| Proceeds from investments | ||||
| Due from affiliates | ||||
| Other assets | ||||
| Consolidated Entity, Excluding VIE | ||||
| Variable Interest Entity, Not Primary Beneficiary | ||||
| Accounts payable and accrued expenses | ||||
| Due to affiliates | ||||
| Accrued performance allocation compensation | ||||
| Other liabilities | ||||
| Consolidated Entity, Excluding VIE | ||||
| Variable Interest Entity, Not Primary Beneficiary | ||||
| Cash and cash equivalents related to consolidated Public SPACs | ||||
| Assets held in Trust Accounts | ||||
| Assets and liabilities, net related to consolidated Public SPACs | ||||
| Net cash provided by operating activities | ||||
| Investing activities: | ||||
| Acquisition | ||||
| Peppertree | ||||
| Angelo Gordon | ||||
| Total acquisition | ||||
| Repayments of notes receivable from affiliates | ||||
| Advances on notes receivable from affiliates | ||||
| Purchases of fixed assets | ||||
| Transfers related to Reorganization Activities | ||||
| Net cash used in investing activities | ||||
| Financing activities: | ||||
| Proceeds from issuance of common stock in IPO, net of underwriting and issuance costs | ||||
| Variable Interest Entity, Not Primary Beneficiary | ||||
| Total proceeds from issuance of common stock in IPO, net of underwriting and issuance costs | ||||
| Proceeds from issuance of common stock from underwriters' exercise of over-allotment option, net of underwriting and issuance costs | ||||
| Purchase of partnership interests with IPO proceeds | ||||
| Consolidated Entity, Excluding VIE | ||||
| Variable Interest Entity, Not Primary Beneficiary | ||||
| Total purchase of partnership interests with IPO proceeds | ||||
| Reorganization activities | ||||
| Proceeds from debt obligations | ||||
| Repayment of debt obligations | ||||
| Issuance costs on debt obligations | ||||
| Withholding taxes paid on net settlement of equity-based awards | ||||
| Contributions from holders of other non-controlling interests | ||||
| Consolidated Entity, Excluding VIE | ||||
| Total contributions from holders of other non-controlling interests | ||||
| Dividends/Distributions | ||||
| Settlement of contingent liabilities | ||||
| Tax receivable agreement payments | ||||
| Payments of underwriting and offering costs | ||||
| Redemption of redeemable equity | ||||
| Proceeds from Noncontrolling Interests | ||||
| Variable Interest Entity, Not Primary Beneficiary | ||||
| Net cash used in financing activities | ||||
| Net change in cash, cash equivalents and restricted cash | ||||
| Cash, cash equivalents and restricted cash, beginning of period | ||||
| Cash, cash equivalents and restricted cash, end of period | ||||
| Supplemental disclosures of other cash flow information: | ||||
| Cash paid for income taxes | ||||
| Cash paid for interest | ||||
| Investment in equity method investments | ||||
| In-kind proceeds from investments | ||||
| Increase in due from affiliates | ||||
| Reorganization | ||||
| NewQuest contingent consideration | ||||
| Deferred underwriting related to Public SPACs | ||||
| Distributions in-kind to holders of other non-controlling interests | ||||
| Distributions payable to partners | ||||
| Distributions payable to holders of other non-controlling interests | ||||
| Repayments of notes receivable to affiliates | ||||
| Reconciliation of cash, cash equivalents and restricted cash, end of period: | ||||
| Cash and cash equivalents | ||||
| Consolidated Entity, Excluding VIE | ||||
| Variable Interest Entity, Not Primary Beneficiary | ||||
| Total cash and cash equivalents | ||||
| Restricted cash | ||||
Loading...